NKG2A is expressed in nearly 50% of NK cells in peripheral blood, while HLA-E expression is low in normal tissue cells but elevated in tumor-infiltrating NK cells, CD8+ T cells, and tumor cells (131). The gene discussed is HLA-E; the disease is neoplasm.